OAC
GMAB icon

OMERS Administration Corp’s Genmab GMAB Stock Holding History

OMERS Administration Corp’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-20,200
Closed -$620K – 1172
2025
Q3 		$620K Buy
+20,200
New +$492K ﹤0.01% 678
2025
Q1 		– Sell
-18,100
Closed -$378K – 1072
2024
Q4 		$378K Buy
+18,100
New +$398K ﹤0.01% 765

Other funds holding GMAB

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

OMERS Administration Corp's GMAB Position: Q4 2025 in Review

OMERS Administration Corp sold out of Genmab (GMAB) in Q4 2025, closing a stake of 20,200 shares — an estimated $620K sold.

OMERS Administration Corp first reported a position in GMAB in Q4 2024 and held it in 2 quarters. The position peaked at $620K in Q3 2025. 293 funds tracked by Wall St. Rank hold GMAB as of Q4 2025.

  • OMERS Administration Corp reported no remaining Genmab position as of Q4 2025 after selling out during the quarter.
  • OMERS Administration Corp sold 20,200 Genmab shares in Q4 2025, an estimated $620K.
  • OMERS Administration Corp first reported a position in Genmab in Q4 2024 and held it in 2 quarters.
  • OMERS Administration Corp's Genmab position peaked at $620K in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Genmab as of Q4 2025.

Based on OMERS Administration Corp's 13F filing for Q4 2025, filed 13 Feb 2026.